CDMRP is Coming

What is CDMRP?

CDMRP stands for “Congressionally Directed Medical Research Programs.” It operates out of the DoD/DoW and through the Defense Health Agency (DHA). Its funding comes directly from the FY26 Defense Appropriations Act passed on February 3rd, 2026.

CDMRP is designed to fund novel Biotech and MedTech solutions to the medical needs of “Service Members and their Families, Veterans and the general public.” You can see the full list of indications and programs to the right of this page.

CDMRP Program Executive Summaries

• Breast Cancer Research Program (BCRP)

• Lupus Research Program (LRP)

• Pancreatic Cancer Research Program (PCARP)

• Tick-Borne Disease Research Program (TBDRP)

• Ovarian Cancer Research Program (OCRP)

• Amyotrophic Lateral Sclerosis Research Program (ALSRP)

• Arthritis Research Program (ATRP)

• Spinal Cord Injury Research Program (SCIRP)

• Tuberous Sclerosis Complex Research Program (TSCRP)

• Multiple Sclerosis Research Program (MSRP)

• Melanoma Research Program (MRP)

Although CDMRP contract awards are highly competitive, boasting a 5% success rate across the board, BW&CO has a history of success and is able to help your company navigate the difficult requirements and complicated application process.

As the pre-solicitations are published, we encourage you to become familiar and submit your project to our team below for a free assessment to ensure alignment to CDMRP’s funding prerogative. Deadlines are typically posted over the Summer and into September.